Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes
CC-486(口服阿扎胞苷)治疗低危骨髓增生异常综合征患者的III期随机、安慰剂对照试验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.20.02619
Garcia-Manero, Guillermo; Santini, Valeria; Almeida, Antonio; Platzbecker, Uwe; Jonasova, Anna; Silverman, Lewis R; Falantes, Jose; Reda, Gianluigi; Buccisano, Francesco; Fenaux, Pierre; Buckstein, Rena; Diez Campelo, Maria; Larsen, Stephen; Valcarcel, David; Vyas, Paresh; Giai, Valentina; Olíva, Esther Natalie; Shortt, Jake; Niederwieser, Dietger; Mittelman, Moshe; Fianchi, Luana; La Torre, Ignazia; Zhong, Jianhua; Laille, Eric; Lopes de Menezes, Daniel; Skikne, Barry; Beach, C L; Giagounidis, Aristoteles